About Us
Company Profile
GCBC Vaccines Pvt. Ltd., a leader in vaccine development, originated from Shantha Biotechnics, India’s first company to develop a recombinant human healthcare product. Since 1991, we have focused on providing affordable healthcare solutions, particularly vaccines. We work with global health organizations like WHO, UNICEF, and PAHO to make vaccines accessible to all.
History & Milestones
- 1991: Shantha Biotechnics founded.
- 1998: Large-scale production of Hepatitis B vaccine.
- 2009: Acquisition by Sanofi Pasteur.
- 2024: Transition of vaccine operations to GCBC Vaccines.
Mission
To make a positive impact on global health by providing vaccines through breakthroughs and innovations.
Vision
To lead in vaccine discovery, ensuring global access and sustainability.
Values
Innovation, Integrity, Collaboration, Excellence, Respect, Sustainability.
Quality & Safety Philosophy
We ensure the highest safety and efficacy standards in our vaccine production through rigorous testing, continuous monitoring, and ethical practices.
